Extracorporeal artificial liver support in hypoxic liver injury

Liver International

Volumn 31, Issue SUPPL. 3, 2011, Pages 19-23

  Drolz, Andreas ^a   Saxa, Reinhard ^a   Scherzer, Thomas ^a   Fuhrmann, Valentin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acute liver failure; Hypoxic hepatitis; Ischemic hepatitis; MARS; Shock liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOGENIC SHOCK; DISEASE ASSOCIATION; DISEASE SEVERITY; GLASGOW COMA SCALE; HEPATITIS; HEPATOPULMONARY SYNDROME; HUMAN; HYPOGLYCEMIA; HYPOXIC HEPATITIS; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CIRRHOSIS; LIVER ISCHEMIA; LIVER PERFUSION; LIVER SUPPORT; MORTALITY; OXYGEN SUPPLY; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW; SCLEROSING CHOLANGITIS; SEPTIC SHOCK; VASCULARIZATION;

ANOXIA; ASPARTATE AMINOTRANSFERASES; HEPATITIS; HUMANS; RENAL DIALYSIS; REPERFUSION INJURY; SHOCK, SEPTIC; SORPTION DETOXIFICATION; TREATMENT OUTCOME;

EID: 79961203312     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02583.x     Document Type: Review

References (16)

1. Whitehead MW, Hawkes ND, Hainsworth I, Kingham JG. A prospective study of the causes of notably raised aspartate aminotransferase of liver origin. Gut 1999; 45: 129-33.
2. Henrion J, Schapira M, Luwaert R, et al. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) 2003; 82: 392-406.
3. Fuhrmann V, Kneidinger N, Herkner H, et al. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 2009; 35: 1397-405.
4. Fuhrmann V, Jager B, Zubkova A, Drolz A. Hypoxic hepatitis - epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr 2010; 122: 129-39.
5. Raurich JM, Perez O, Llompart-Pou JA, et al. Incidence and outcome of ischemic hepatitis complicating septic shock. Hepatol Res 2009; 39: 700-5.
6. Lautt WW. Regulatory processes interacting to maintain hepatic blood flow constancy: vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction. Hepatol Res 2007; 37: 891-903.
7. Henrion J, Descamps O, Luwaert R, et al. Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow. J Hepatol 1994; 21: 696-703.
8. Henrion J. Ischemia/reperfusion injury of the liver: pathophysiologic hypotheses and potential relevance to human hypoxic hepatitis. Acta Gastroenterol Belg 2000; 63: 336-47.
9. Mesotten D, Wauters J, Van den Berghe G, et al. The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients. J Clin Endocrinol Metab 2009; 94: 2345-52.
10. Fuhrmann V, Madl C, Mueller C, et al. Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology 2006; 131: 69-75.
11. Ruemmele P, Hofstaedter F, Gelbmann CM. Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 2009; 6: 287-95.
12. Abdalian R, Heathcote EJ. Sclerosing cholangitis: a focus on secondary causes. Hepatology 2006; 44: 1063-74.
13. Engler S, Elsing C, Flechtenmacher C, et al. Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. Gut 2003; 52: 688-93.
14. Mitzner SR, Klammt S, Peszynski P, et al. Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. Ther Apher 2001; 5: 417-22.
15. Sen S, Mookerjee RP, Cheshire LM, et al. Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis. J Hepatol 2005; 43: 142-8.
16. El Banayosy A, Kizner L, Schueler V, et al. First use of the Molecular Adsorbent Recirculating System technique on patients with hypoxic liver failure after cardiogenic shock. ASAIO J 2004; 50: 332-7.